Cargando…
Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy
Sjogren’s Syndrome is a chronic autoimmune disorder that causes the inflammation of the lacrimal and salivary glands, resulting in dryness of the eyes and mouth. In addition, fatigue and musculoskeletal pain, often described as aching, is very common. Treatment directed toward alleviating the fatigu...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510571/ https://www.ncbi.nlm.nih.gov/pubmed/31123647 http://dx.doi.org/10.7759/cureus.4225 |
_version_ | 1783417441448099840 |
---|---|
author | Zashin, Scott |
author_facet | Zashin, Scott |
author_sort | Zashin, Scott |
collection | PubMed |
description | Sjogren’s Syndrome is a chronic autoimmune disorder that causes the inflammation of the lacrimal and salivary glands, resulting in dryness of the eyes and mouth. In addition, fatigue and musculoskeletal pain, often described as aching, is very common. Treatment directed toward alleviating the fatigue and pain associated with Sjogren’s is currently very limited. This report describes a case of a 47-year-old female with suspected Sjogren's based on long-standing dry eyes, dry mouth, joint pain, fatigue, elevated measures of inflammation, and a positive rheumatoid factor. She failed standard therapy but improved clinically with low-dose naltrexone therapy. |
format | Online Article Text |
id | pubmed-6510571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-65105712019-05-23 Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy Zashin, Scott Cureus Internal Medicine Sjogren’s Syndrome is a chronic autoimmune disorder that causes the inflammation of the lacrimal and salivary glands, resulting in dryness of the eyes and mouth. In addition, fatigue and musculoskeletal pain, often described as aching, is very common. Treatment directed toward alleviating the fatigue and pain associated with Sjogren’s is currently very limited. This report describes a case of a 47-year-old female with suspected Sjogren's based on long-standing dry eyes, dry mouth, joint pain, fatigue, elevated measures of inflammation, and a positive rheumatoid factor. She failed standard therapy but improved clinically with low-dose naltrexone therapy. Cureus 2019-03-11 /pmc/articles/PMC6510571/ /pubmed/31123647 http://dx.doi.org/10.7759/cureus.4225 Text en Copyright © 2019, Zashin et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Zashin, Scott Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy |
title | Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy |
title_full | Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy |
title_fullStr | Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy |
title_full_unstemmed | Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy |
title_short | Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy |
title_sort | sjogren's syndrome: clinical benefits of low-dose naltrexone therapy |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510571/ https://www.ncbi.nlm.nih.gov/pubmed/31123647 http://dx.doi.org/10.7759/cureus.4225 |
work_keys_str_mv | AT zashinscott sjogrenssyndromeclinicalbenefitsoflowdosenaltrexonetherapy |